DEFIANCE: Randomized Clinical Trial of ClotTriever system versus anticoagulation in Deep Vein Thrombosis
Volunteers
Health Professionals
What is the purpose of this trial?
This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clinical outcomes through the 6-month follow up visit.
Currently enrolling patients with:
- Iliofemoral and unilateral DVT
- Symptom onset within 12 weeks of enrollment in the study
Follow-up schedule:
- Patients follow-up tp 6 months
Mechanical thrombectomy with the ClotTriever
Single session procedure
- No thrombolytics or ICU stay required
- Trial withInari Medical
- Ages18 years and older
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Last Updated07/23/2024
- Study HIC#2000034032